Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD

110.91  -2.22 (-1.96%)

After market: 110.91 0 (0%)

Fundamental Rating

6

Taking everything into account, ADUS scores 6 out of 10 in our fundamental rating. ADUS was compared to 102 industry peers in the Health Care Providers & Services industry. While ADUS has a great profitability rating, there are some minor concerns on its financial health. ADUS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
In the past year ADUS had a positive cash flow from operations.
In the past 5 years ADUS has always been profitable.
Each year in the past 5 years ADUS had a positive operating cash flow.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

ADUS has a better Return On Assets (5.61%) than 81.37% of its industry peers.
With a decent Return On Equity value of 7.94%, ADUS is doing good in the industry, outperforming 69.61% of the companies in the same industry.
ADUS has a better Return On Invested Capital (6.56%) than 67.65% of its industry peers.
ADUS had an Average Return On Invested Capital over the past 3 years of 7.23%. This is below the industry average of 9.59%.
Industry RankSector Rank
ROA 5.61%
ROE 7.94%
ROIC 6.56%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

ADUS's Profit Margin of 6.52% is amongst the best of the industry. ADUS outperforms 83.33% of its industry peers.
In the last couple of years the Profit Margin of ADUS has grown nicely.
ADUS has a better Operating Margin (9.04%) than 78.43% of its industry peers.
In the last couple of years the Operating Margin of ADUS has grown nicely.
Looking at the Gross Margin, with a value of 32.56%, ADUS is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
In the last couple of years the Gross Margin of ADUS has grown nicely.
Industry RankSector Rank
OM 9.04%
PM (TTM) 6.52%
GM 32.56%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ADUS is destroying value.
Compared to 1 year ago, ADUS has more shares outstanding
The number of shares outstanding for ADUS has been increased compared to 5 years ago.
Compared to 1 year ago, ADUS has a worse debt to assets ratio.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 4.58 indicates that ADUS is not in any danger for bankruptcy at the moment.
ADUS's Altman-Z score of 4.58 is amongst the best of the industry. ADUS outperforms 80.39% of its industry peers.
The Debt to FCF ratio of ADUS is 2.21, which is a good value as it means it would take ADUS, 2.21 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ADUS (2.21) is better than 80.39% of its industry peers.
ADUS has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.20, ADUS is doing good in the industry, outperforming 68.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.21
Altman-Z 4.58
ROIC/WACC0.77
WACC8.57%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ADUS has a Current Ratio of 1.74. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ADUS (1.74) is better than 64.71% of its industry peers.
ADUS has a Quick Ratio of 1.74. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ADUS (1.74) is better than 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

ADUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.74%, which is quite good.
The Earnings Per Share has been growing by 16.61% on average over the past years. This is quite good.
Looking at the last year, ADUS shows a quite strong growth in Revenue. The Revenue has grown by 11.38% in the last year.
ADUS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.22% yearly.
EPS 1Y (TTM)14.74%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%17.36%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%20.29%

3.2 Future

Based on estimates for the next years, ADUS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.50% on average per year.
ADUS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.53% yearly.
EPS Next Y18.12%
EPS Next 2Y14.2%
EPS Next 3Y13.26%
EPS Next 5Y10.5%
Revenue Next Year21.5%
Revenue Next 2Y13.32%
Revenue Next 3Y11.16%
Revenue Next 5Y8.53%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.35 indicates a rather expensive valuation of ADUS.
ADUS's Price/Earnings ratio is a bit cheaper when compared to the industry. ADUS is cheaper than 67.65% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.25, ADUS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.23, ADUS is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 70.59% of the companies listed in the same industry.
ADUS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 20.35
Fwd PE 16.23
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 61.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.64
EV/EBITDA 17.34
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADUS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 13.26% in the coming years.
PEG (NY)1.12
PEG (5Y)1.23
EPS Next 2Y14.2%
EPS Next 3Y13.26%

0

5. Dividend

5.1 Amount

No dividends for ADUS!.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (5/30/2025, 8:00:00 PM)

After market: 110.91 0 (0%)

110.91

-2.22 (-1.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners103.89%
Inst Owner Change1.49%
Ins Owners1.73%
Ins Owner Change3.78%
Market Cap2.04B
Analysts81.18
Price Target138.41 (24.79%)
Short Float %4.48%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.46%
Min EPS beat(2)0.48%
Max EPS beat(2)4.43%
EPS beat(4)3
Avg EPS beat(4)3.31%
Min EPS beat(4)-0.68%
Max EPS beat(4)9%
EPS beat(8)7
Avg EPS beat(8)5.05%
EPS beat(12)10
Avg EPS beat(12)5.22%
EPS beat(16)12
Avg EPS beat(16)4.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.45%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.22%
Revenue beat(12)0
Avg Revenue beat(12)-1.5%
Revenue beat(16)0
Avg Revenue beat(16)-1.89%
PT rev (1m)0%
PT rev (3m)-3.63%
EPS NQ rev (1m)0.82%
EPS NQ rev (3m)0.52%
EPS NY rev (1m)0.38%
EPS NY rev (3m)2.15%
Revenue NQ rev (1m)-1.14%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 20.35
Fwd PE 16.23
P/S 1.68
P/FCF 22.64
P/OCF 21.1
P/B 2.05
P/tB N/A
EV/EBITDA 17.34
EPS(TTM)5.45
EY4.91%
EPS(NY)6.83
Fwd EY6.16%
FCF(TTM)4.9
FCFY4.42%
OCF(TTM)5.26
OCFY4.74%
SpS65.85
BVpS54.1
TBVpS-4.6
PEG (NY)1.12
PEG (5Y)1.23
Profitability
Industry RankSector Rank
ROA 5.61%
ROE 7.94%
ROCE 8.7%
ROIC 6.56%
ROICexc 7.11%
ROICexgc 99.98%
OM 9.04%
PM (TTM) 6.52%
GM 32.56%
FCFM 7.44%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score5
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.21
Debt/EBITDA 1.61
Cap/Depr 47.01%
Cap/Sales 0.54%
Interest Coverage 14.16
Cash Conversion 78.26%
Profit Quality 114.08%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 4.58
F-Score5
WACC8.57%
ROIC/WACC0.77
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)14.74%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%17.36%
EPS Next Y18.12%
EPS Next 2Y14.2%
EPS Next 3Y13.26%
EPS Next 5Y10.5%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%20.29%
Revenue Next Year21.5%
Revenue Next 2Y13.32%
Revenue Next 3Y11.16%
Revenue Next 5Y8.53%
EBIT growth 1Y13.78%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year43.57%
EBIT Next 3Y17.53%
EBIT Next 5Y14.43%
FCF growth 1Y-18.04%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-18%
OCF growth 3Y43.4%
OCF growth 5Y57.54%